好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ataxia and Azoospermia Caused by an MT-ATP6 Mutation with Apparent Anticipation due to Heteroplasmy in a Large Extended Kindred
Movement Disorders
P4 - Poster Session 4 (8:00 AM-9:00 AM)
16-011

This study aimed to investigate whether heteroplasmy in the MT-ATP6 gene is associated with the age of onset and clinical features of ataxia in an affected family.

Mutations in mitochondrial-encoded genes, particularly MT-ATP6, have been implicated in neurodegenerative disorders, including certain forms of progressive ataxia. In addition to allelic variation, repeat expansion instability, and modifier genes, variations in heteroplasmy may also be related to phenotypic variability in cerebellar ataxias.
We analyzed mitochondrial DNA samples from 48 members of a five-generation kindred exhibiting features of progressive ataxia and cognitive impairment, for which testing for repeat expansions associated with the SCAs was negative. Genotyping was compared alongside cognitive profiles, fertility evaluations, and clinical data.

The variant m.9035 T>C in MT-ATP6 was detected in all affected individuals. Specifically, the age of onset of ataxia, ranging from early childhood to the 8th decade, was inversely correlated with heteroplasmy levels. We also identified two additional clinical features associated with the mtDNA mutation: male infertility (azoospermia) and decreased intellectual ability in individuals with ataxia. Male infertility appeared to segregate with the mitochondrial mutation. Detailed neuropsychological evaluations demonstrated mild intellectual disability to low average range intellectual ability for those with onset of ataxia before 40 years of age. Cognitive and motor function in the ataxia group inversely correlated with heteroplasmy percentages.

In summary, this study expands the known phenotype of MT-ATP6-related diseases. We report a large multigenerational family with a constellation of neurologic, cognitive, and reproductive phenotypes due to a known pathogenic mtDNA variant in MT-ATP6 (m.9035T>C). Notably, we also observed an apparent association between the MT-ATP6 m.9035T>C variant and male infertility. It remains to be determined whether the male infertility is specific to the m.9035T>C variant or might be observed more broadly across other pathogenic MT-ATP6 mutations.

Authors/Disclosures
David Zhu
PRESENTER
Mr. Zhu has nothing to disclose.
Changrui Xiao, MD (UC Irvine) Dr. Xiao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WIley. The institution of Dr. Xiao has received research support from NIH.
Jon L. Pryor, MD Dr. Pryor has nothing to disclose.
Sally Frutiger, PhD Dr. Frutiger has nothing to disclose.
Brent Clark Brent Clark has nothing to disclose.
Hannah L. Casey Miss Casey has nothing to disclose.
Matthew Bower, MS, CGC Mr. Bower has nothing to disclose.
Annie Yu Ms. Yu has nothing to disclose.
xiaofei du, MD Dr. du has nothing to disclose.
Camilo Toro, MD, FAAN (NIH) Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Christopher Gomez, MD, PhD (University of Chicago) Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.